Filter
110
Filtered Results: 110
Text search:
Yap,
J.
Featured
Recommendations
13
New Publications
39
Language
Document type
No document type
54
Guidelines
26
Studies & Reports
13
Manuals
5
Fact sheets
5
Training Material
4
Strategic & Response Plan
2
Situation Updates
1
Countries / Regions
Brazil
12
Mozambique
4
Global
4
India
4
Venezuela
3
Russia
3
Philippines
2
Africa
2
Haiti
2
Western and Central Europe
2
Angola
2
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Cameroon
1
Malawi
1
Guinea
1
Italy
1
Cambodia
1
Asia
1
Tanzania
1
Germany
1
South–East Asia Region
1
Paraguay
1
Bangladesh
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
29
Public Health
5
Clinical Guidelines
5
Women & Child Health
3
Pharmacy & Technologies
3
Capacity Building
1
Key Resources
1
Toolboxes
COVID-19
33
Zika
30
Mental Health
8
Rapid Response
5
HIV
4
Planetary Health
4
NTDs
3
NCDs
3
Cholera
2
Ebola
2
Global Health Education
2
Refugee
1
Disability
1
Pharmacy
1
Health Financing Toolbox
1
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
This brief summarizes current evidence and guidance for maintaining safe and effective care across the spectrum of maternal, newborn and infant care while protecting mother and child and health care providers during COVID-19. Furthermore, implications of the principle of “do no harm” are reviewe...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalizaçã...
PlosOne Published: July 14, 2021
https://doi.org/10.1371/journal.pone.0254339
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Training Modules for climate change and Health - WHO
The frequency of infectious disease epidemics is increasing, and the role of the health sector in the management of epidemics is crucial in terms of response. In the context of infectious disease epidemics, the use of climate-informed early warning systems (EWS) has the potential to increase the eff...
Guideline for the development of a national plan for the operationalization of vaccination against COVID-19
